Basics Kala Pharmaceuticals, Inc. Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases. IPO Date: July 20, 2017 Sector: Healthcare Industry: Biotech Market Cap: $17.62M Activated in VL: True Average Daily Range Avg Daily Range: $0.30 | 3.79% Avg Daily Range (30 D): $0.05 | 5.81% Avg Daily Range (90 D): $0.23 | 5.74% Institutional Daily Volume Avg Daily Volume: .85M Avg Daily Volume (30 D): 7.38M Avg Daily Volume (90 D): 4.78M Trade Size Avg Trade Size (Sh.): 201 Avg Trade Size (Sh.) (30 D): 414 Avg Trade Size (Sh.) (90 D): 333 Institutional Trades Total Inst.Trades: 195 Avg Inst. Trade: $1.54M Avg Inst. Trade (30 D): $.59M Avg Inst. Trade (90 D): $.59M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.4M Avg Closing Trade (30 D): $.59M Avg Closing Trade (90 D): $.59M Avg Closing Volume: 7.21K     News Dec 5, 2025 @ 7:36 PM KALA BIO Announces Closing of $10 Million Register... Source: David Lazar Sep 29, 2025 @ 5:14 PM Crude Oil Falls Sharply; Carnival Posts Upbeat Ear... Source: Avi Kapoor Sep 29, 2025 @ 5:06 PM 12 Health Care Stocks Moving In Monday's Intraday ... Source: Benzinga Staff Writer Sep 29, 2025 @ 2:11 PM Nasdaq Jumps 150 Points; US Pending Home Sales Ris... Source: Avi Kapoor Aug 8, 2025 @ 12:18 PM Kala Bio (KALA) Q2 Loss Widens 15% Source: Jesterai Financials   TTM Q3 2025 Q2 2025 Basic EPS $-5.67 $-1.07 $-1.71 Diluted EPS $-5.67 $-1.07 $-1.71 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -35.84M $ -7.56M $ -11.16M Operating Income / Loss $ -38.4M $ -7.24M $ -11.03M Cost of Revenue $ $ $ Net Cash Flow $ -28.11M $ -10.85M $ -16.56M PE Ratio     Splits Oct 21, 2022:   1:50 Aug 26, 2022:   1.00:1